¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ectrodactyly-ectodermal dysplasia clefting syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • alports syndrome
    ¾ËÆ÷¿ÀÆ®ÁõÈıº
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
  • alveolar hypoventilation syndrome
    ÆóÆ÷Àúȯ±âÁõÈıº.
  • alveolar-capillary block syndrome
    ÆóÆ÷-¸ð¼¼Ç÷°üÂ÷´ÜÁõÈıº.
  • amelo-cerebro-hypohidrotic syndrome
    ¿¡³ª¸á-´ë³ú-¶¡°ú¼ÒÁõÈıº
  • amniotic band syndrome
    ¾ç¸·´ëÁõÈıº(¡­Óáñøý¦ÏØ)
  • androgen insensitivity syndrome
    ¾Èµå·Î°Õ( ³²¼ºÈ£¸£¸ó) ºÒ°¨¼º ÁõÈıº(ÝÕÊïàõ ñøý¦ÏØ)
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
  • anginal syndrome
    Çù½ÉÁõÁõÈıº (¡­ñøñøý¦ÏØ).
  • anorectal syndrome
    Ç×¹®Á÷ÀåÁõÈıº(ùýÚ¦òÁ ñøý¦ÏØ).
  • anorectal syndrome
    Ç×¹®Á÷ÀåÁõÈıº(Ç×¹®Á÷ÀåÁõÈıº).
  • anterior chamber cleavage syndrome
    Àü¹æ(°¢)ºÐ¸®ºÎÀüÁõÈıº
  • anterior choroidal artery occlusion syndrome
    Àü¸Æ¶ôÃѵ¿¸Æ Æó¼âÁõÈıº.
  • anterior cornual syndrome
    Àü°¢ÁõÈıº(îñÊÇñøý¦ÏØ).
  • anterior scalene syndrome
    Àü»ç°¢±ÙÁõÈıº(îñÞØÊÇÐÉñøý¦ÏØ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • denys-drash syndrome
    Denys-DrashÁõÈıº(¡­ñøý¦ÏØ)
  • depersonalization-derealization syndrome
    ÀÌÀÎ-ºñÇö½Ç°¨ ÁõÈıº(ì¶ìÑ-ÞªúÞãùÊï ñøý¦ÏØ)
  • dermatorheumatismal syndrome
    ÇǺηù¸¶Æ¼½ºÁõÈıº(¡­ñøý¦ÏØ).
  • diencephalic syndrome
    °£³úÁõÈıº(ÊàÒàñøý¦ÏØ).
  • digeorge syndrome
    DiGeorge ÁõÈıº(¡­ñøý¦ÏØ), µðÁÒ¿ÀÁö ÁõÈıº
  • disappearing bile duct syndrome
    ´ãµµ¼Ò½ÇÁõÈıº
  • discontinuation syndrome
    ºÒ¿¬¼Ó¼º ÁõÈıº
  • discrete multiple endocrine adenomatosis syndrome
    ºÐ¸®¼º ´Ù¹ß ³»ºÐºñ¼±Á¾ ÁõÈıº(ÝÂìÆàõÒýÛ¡Ò®ÝÂù²àÍðþñøý¦ÏØ).
  • dissacharidase deficiency syndrome
    ÀÌ´ç·ùºÐÇØÈ¿¼Ò °áÇÌÁõÈıº(¡­ÌÀù¹ñøý¦ÏØ ).
  • dorsal midbrain syndrome
    ÈÄÁß³úÁõÈıº
  • double crush syndrome
    ÀÌÁß ºÐ¼â ÁõÈıº
  • down syndrome
    ´Ù¿îÁõÈıº(¡­ñøý¦ÏØ)
  • downs syndrome
    ´Ù¿îÁõÈıº
  • dresslers syndrome
    dresslerÁõÈıº
  • dresslers syndrome
    µå·¹½½·¯ ÁõÈıº(¡­ñøý¦ÏØ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
OSMED otospondylometaphyseal dysplasia
PAMD primary adrenocortical micronodular dysplasia
PAND primary adrenocortical nodular dysplasia
PAT-SED pseudoachondroplastic dysplasia
PFD polyostotic fibrous dysplasia; pseudoinflammatory fundus disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
DSPS Delayed Sleep Phase Syndrome
DHF/DSS Dengue Haemorrhagic Fever/Dengue Shock Syndrome
DSS Dengue Shock Syndrome
DDS Denys Drash syndrome
DGS Di George syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • milk alkali syndrome
    ¿ìÀ¯ ¾ËÄ®¸® ÁõÈıº
    ¿À·£ ±â°£ µ¿¾È ¿ìÀ¯¿Í Èí¼ö¼º ¾ËÄ®¸® Á©À» ¼¶ÃëÇÔÀ¸·Î½á ÃÊ·¡µÇ´Â °íÄ®½· Ç÷Áõ¿¡ ÀÇÇÏ¿© ÀϾ´Â ÁõÈıºÀÌ´Ù. °íÄ®½· ´¢ÁõÀ̳ª ÀúÀλó Ç÷ÁõÀº ¼ö¹ÝµÇÁö ¾ÊÀ¸³ª, ÁߵÀÇ alaklosis, Á¤»ó Ç÷û
  • mineralocorticoid exess syndrome
    ¿°·ù ÄÚ¸£Æ¼ÄÚÀ̵å Áõ´ÙÁõ
  • mixed cryoglobulin syndrome
    È¥ÇÕ Çѳà ±Û·ÎºÒ¸° ÁõÈıº
  • monofixation syndrome
    ´Ü¾È Áֽà ÁõÈıº
  • motor syndrome
    ¿îµ¿ ÁßÃß ÁõÈıº
  • mucocutaneous ocular syndrome
    ÇǺΠÁ¡¸· ¾È ÁõÈıº
  • Muenchausen's syndrome
    ¹Â¿£ÇÏ¿ìÁ¨ ÁõÈıº
    ±Ø´ÜÀûÀÎ ÇãÀ§ÀÇ º´·ÂÀ» ¸»Çϸç, ¶§·Î´Â ±Þ¼º º¹ºÎ Áõ»ó, ƯÈ÷ ÃâÇ÷, ¿Ü»ó µîÀ» °¡ÀåÇϸ鼭 ÀÔ¿øÀ» ÇÏ´Ù°¡ ÀÚ¹ßÀûÀ¸·Î Åð¿øµµ ÇÏ´Â ±â±«ÇÑ »óÅ·Π´ë°³ È÷½ºÅ׸®, ºÐ¿­Áõ ¶Ç´Â ÇÇÇã¾Ö ȯÀÚ.
  • multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
    ´Ù¹ß¼ºÀÌ¸ç ¸ð¹Ý ¸ð¾çÀÎ ¿Ü¹è¿±¼º, Á߹迱¼º ¹× ³»¹è¿±¼ºÀÇ ½Å»ý¹°¼º ±âÇüÀ» Ư¡À¸·Î ÇÏ´Â À¯Àüº´. ¾ó±¼ ¹× ±¸°­ Á¡¸·ÀÇ ±¸ÁøÀÌ °¡Àå Æ¯Â¡ÀûÀÎ º´º¯ÀÌ´Ù. ±× ¿ÜÀÇ º´º¯Àº ÇǺÎ, °©»ó¼±
  • multiple lentigines syndrome
    ´Ù¹ß¼º ÈæÀÚ ÁõÈıº
    »ó¿°»öü¼º ¿ì¼ºÀÇ À¯Àü¼º ÁõÈıºÀ¸·Î¼­ ´Ù¹ß¼º °ËÀº »ç¸¶±Í, ¹«ÁõÈıº¼º ½ÉÀå °áÇÔ. ƯÀÌÇÑ ¾ó±¼ ¸ð¾ç, Æóµ¿¸Æ ÇùÂø, Áö°¢ ½Å°æ¼º ³­Ã», °ñ°Ý ÀÌ»ó, ¾ç¾È °Ý¸®, ¼º±â ±âÇü µîÀ» ³ªÅ¸³½´Ù.
  • multiple neuroma syndrome
    ´Ù¹ß¼º ½Å°æÁ¾ ÁõÈıº
  • Munchausen's syndrome
    ½Åü Áõ»óÀ» ¼ö¹ÝÇÑ °¡À强 Áúȯ
    ÀüºÎ °ÅÁþ¸»ÀÎ ±×·²µíÇÑ º´·ÂÀ» À̾߱âÇϸ鼭 ½À°üÀûÀ¸·Î ÀÔ¿ø Ä¡·á¸¦ ¹Þ´Â »óÅÂ.
  • muscle compartment syndrome
    ±Ù ±¸¿ª ÁõÈıº
    ±Ù ±¸¿ª ³»ÀÇ »ê¼Ò ºÎÁ·À¸·Î ÀÎÇÏ¿© ±ÙÀ°¿¡ ÅëÁõÀ̳ª »»»»ÇÔÀÌ ¹ß»ýÇÑ °Í.
  • myasthenia gravis syndrome
    ÁßÁõ ±Ù¹«·Â ÁõÈıº
  • myeloblastic syndrome
    °ñ¼ö¾Æ±¸ ÁõÈıº
  • myelodysplastic syndrome
    °ñ¼ö ÀÌÇü¼º ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
marfan syndrome <radiology> Connective-tissue disorder: autosomal dominant, 15% sporadic, cardiovascular system (probable cause of death in 93%), aortic aneurysm (mostly ascending), dilatation of aortic sinuses, aortic dissection, coarctation, musculoskeletal system, tall stature, long limbs, arachnodactyly, lax joints, scoliosis (60%) / kyphosis / pectus, eye, lens subluxation Cf: homocystinuria More info: Marfan syndrome
(12 Dec 1998)
Marie-Robinson syndrome <syndrome> Insomnia and mild melancholia associated with alimentary levulosuria.
(05 Mar 2000)
Marinesco-Garland syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
Marinesco-Sjogren syndrome <syndrome> A rare neurologic disorder characterised by cerebellolental degeneration with mental retardation; autosomal recessive inheritance.
Synonym: cataract-oligophrenia syndrome, Marinesco-Sjogren syndrome, Torsten Sjogren's syndrome.
(05 Mar 2000)
verner-morrison syndrome <radiology> WDHA syndrome, watery diarrhoea, hypokalaemia, achlorhydria, vasoactive intestinal peptide (VIP) secreted by, pancreatic isleT-cell tumour (VIPoma)
(12 Dec 1998)
Vernet's syndrome <syndrome> A syndrome characterised by paralysis of the motor components of the glossopharyngeal, vagus, and accessory cranial nerves as they lie in the posterior fossa; it is most commonly the result of head injury.
(05 Mar 2000)
Maroteaux-Lamy syndrome <biochemistry, syndrome> An error of mucopolysaccharide metabolism due to deficiency of the lysosomal enzyme arylsulphatase B.
It is characterised by excretion of dermatan sulfate in the urine, growth retardation, lumbar kyphosis, sternal protrusion, genu valgum, usually hepatosplenomegaly, and no mental retardation.
Onset occurs after two years of age.
Inheritance: autosomal recessive.
Synonym: polydystrophic dwarfism, mucopolysaccharidosis type VI.
(05 Mar 2000)
Marshall syndrome <syndrome> Syndrome of mid-face hypoplasia, cataract, sensorineural hearing loss, and hypohidrosis. It is disputed whether this syndrome is distinct from Stickler's syndrome.
(05 Mar 2000)
carotid artery occlusive syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome.
Characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality.
Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
carotid sinus syndrome <syndrome> Stimulation of a hyperactive carotid sinus, causing a marked fall in blood pressure due to vasodilation, cardiac slowing, or both; syncope with or without convulsions or A-V block may occur.
Synonym: Charcot-Weiss-Baker syndrome.
(05 Mar 2000)
Martorell's syndrome <syndrome> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch. These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
masa syndrome <syndrome> MASA stands for mental retardation, aphasia, shuffling gait, and adducted thumbs.
Features of the syndrome include (1) neurologically: mental retardation and aphasia (lack of speech); (2) limbs: adducted (clasped) thumbs, absent extensor pollicis longus and/or brevis muscles to the thumb, shuffling gait, and leg spasticity; (3) growth: small body size; (4) skeleton: lumbar lordosis (sway back).
It is inherited as an x-linked trait and so affects mainly boys. Alternative names for masa include clasped thumb and mental retardation, congenital clasped thumb with mental retardation, adducted thumb with mental retardation, and the gareis-mason syndrome.
inheritance: X-linked
(29 Dec 1998)
carpal tunnel syndrome <syndrome> A condition where there is a disturbance of median nerve function in the wrist as the nerve passes through the carpal tunnel.
A buildup of scar tissue (inside the carpal tunnel) can lead to this surgically correctable problem. Often treated with splinting and anti-inflammatory agents.
(27 Sep 1997)
Carpenter's syndrome <syndrome> The association of primary hypothyroidism, primary adrenocortical insufficiency, and diabetes mellitus.
Origin: C. C. J. Carpenter
Synonym: acrocephalopolysyndactyly.
Origin: G. Carpenter
(05 Mar 2000)
vertical retraction syndrome <syndrome> A retraction of the globe and pseudoptosis on attempted adduction; due to co-innervation of the horizontal recti. Sometimes there is an inability to abduct the affected eye (type 1), or adduct the affected eye (type 2), or both (type 3).
Synonym: Duane's syndrome.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á